These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32729616)

  • 21. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis.
    Koivula MK; Heliövaara M; Rissanen H; Palosuo T; Knekt P; Immonen H; Risteli J
    Ann Rheum Dis; 2012 Oct; 71(10):1666-70. PubMed ID: 22419777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique correlation between mutated citrullinated vimentine IgG autoantibodies and markers of systemic inflammation in rheumatoid arthritis patients.
    Zahran WE; Mahmoud MI; Shalaby KA; Abbas MH
    Indian J Clin Biochem; 2013 Jul; 28(3):272-6. PubMed ID: 24426223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated Peptide antibodies and rheumatoid factor in omani patients with rheumatoid arthritis.
    Al-Shukaili A; Al-Ghafri S; Al-Marhoobi S; Alkaabi J
    Int J Rheumatol; 2012; 2012():285854. PubMed ID: 22934118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum sirtuin-1 a potential marker in the diagnosis of rheumatoid arthritis.
    Tan L; Ouyang T; Li X; Chen Y; Ke S; Chen J; Liu Y; Zeng F; Chen Y; Long J; Deng Q; Hu X
    Autoimmunity; 2023 Dec; 56(1):2181234. PubMed ID: 36843438
    [No Abstract]   [Full Text] [Related]  

  • 25. Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis.
    Sghiri R; Bouajina E; Bargaoui D; Harzallah L; Fredj HB; Sammoud S; Ghedira I
    Rheumatol Int; 2008 Nov; 29(1):59-62. PubMed ID: 18496693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of the anti-Sa antibody compared with the anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.
    Iwaszkiewicz C; Puszczewicz M; Białkowska-Puszczewicz G
    Int J Rheum Dis; 2015 Jan; 18(1):46-51. PubMed ID: 25488711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of four serum biomarkers in rheumatoid arthritis: association with extra articular manifestations in patients and arthralgia in relatives.
    Nass FR; Skare TL; Goeldner I; Nisihara R; Messias-Reason IT; Utiyama SRR
    Rev Bras Reumatol Engl Ed; 2017; 57(4):286-293. PubMed ID: 28743354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritis-affected families.
    Kim SK; Bae J; Lee H; Kim JH; Park SH; Choe JY
    Korean J Intern Med; 2013 Jan; 28(1):45-53. PubMed ID: 23345996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.
    Vos I; Van Mol C; Trouw LA; Mahler M; Bakker JA; Van Offel J; De Clerck L; Huizinga TW
    Clin Rheumatol; 2017 Jul; 36(7):1487-1492. PubMed ID: 28578492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X; Jia R; Zhao J; Li Z
    J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
    Dejaco C; Klotz W; Larcher H; Duftner C; Schirmer M; Herold M
    Arthritis Res Ther; 2006; 8(4):R119. PubMed ID: 16859519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to mutated citrullinated vimentin in patients with chronic hepatitis C virus genotype IV infection-related arthropathy.
    Zehairy M; Soliman E; Daghaidy A
    Rheumatol Int; 2012 Nov; 32(11):3495-501. PubMed ID: 22068352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-cyclic citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) relation with extra-articular manifestations in rheumatoid arthritis.
    Gonzalez-Lopez L; Rocha-Muñoz AD; Ponce-Guarneros M; Flores-Chavez A; Salazar-Paramo M; Nava A; Cardona-Muñoz EG; Fajardo-Robledo NS; Zavaleta-Muñiz SA; Garcia-Cobian T; Gamez-Nava JI
    J Immunol Res; 2014; 2014():536050. PubMed ID: 24804270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of anti-MCV and anti-CCP antibodies in rheumatoid arthritis: A meta-analysis.
    Lee YH; Bae SC; Song GG
    Z Rheumatol; 2015 Dec; 74(10):911-8. PubMed ID: 26111961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis.
    Wagner E; Skoumal M; Bayer PM; Klaushofer K
    Rheumatol Int; 2009 Sep; 29(11):1315-21. PubMed ID: 19184032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.
    Meyer PWA; Ally MTM; Hodkinson B; Anderson R; Tikly M
    Rheumatol Int; 2018 Jun; 38(6):993-1001. PubMed ID: 29713794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes with HLA-DRB1 shared epitope alleles in Egyptian rheumatoid arthritis patients.
    Raslan HM; Attia HR; Hamed Ibrahim M; Mahmoud Hassan E; Salama II; Ismail S; Abdelmotaleb E; El Menyawi MM; Amr KS
    Int J Rheum Dis; 2020 May; 23(5):647-653. PubMed ID: 32167241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features.
    Alessandri C; Agmon-Levin N; Conti F; Perricone C; Ortona E; Pendolino M; Capozzi A; Delunardo F; Mancini R; Truglia S; Spinelli FR; Ceccarelli F; Sorice M; Shoenfeld Y; Valesini G
    Immunol Res; 2017 Apr; 65(2):524-531. PubMed ID: 28215033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.